ストックスクリーナーアプリを入手
1.24
10.71%
0.12
前日終値:
$1.12
開ける：
$1.11
24時間の取引高:
4.88M
Relative Volume:
0.97
時価総額：
$230.34M
収益：
-
当期純損益:
$-110.78M
株価収益率:
-1.1589
EPS:
-1.07
ネットキャッシュフロー:
$-75.59M
1週間 パフォーマンス:
+0.81%
1か月 パフォーマンス:
-28.32%
6か月 パフォーマンス:
-47.01%
1年 パフォーマンス:
-71.69%
1日の値動き範囲:
$1.09
$1.24
1週間の範囲:
$1.09
$1.26
52週間の値動き範囲:
$1.09
$6.77
Humacyte Inc Stock (HUMA) Company Profile
名前
Humacyte Inc
セクター
電話
919-313-9633
住所
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
HUMA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HUMA
Humacyte Inc
|
1.23 | 209.74M | 0 | -110.78M | -75.59M | -1.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.01 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
761.11 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.15 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
922.65 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
200.22 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Humacyte Inc Stock (HUMA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-27 | 開始されました | Barclays | Overweight |
| 2025-05-14 | 再開されました | H.C. Wainwright | Buy |
| 2024-12-20 | 繰り返されました | H.C. Wainwright | Buy |
| 2023-12-11 | 開始されました | H.C. Wainwright | Buy |
| 2023-08-14 | アップグレード | Piper Sandler | Underweight → Neutral |
| 2023-06-22 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-05-16 | ダウングレード | Piper Sandler | Overweight → Underweight |
| 2021-10-29 | 開始されました | Cowen | Outperform |
| 2021-09-24 | 開始されました | Oppenheimer | Outperform |
| 2021-09-22 | 開始されました | BTIG Research | Buy |
| 2021-09-16 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Humacyte Inc (HUMA) 最新ニュース
Quantitative breakdown of Humacyte Inc. recent moveMarket Movers & Long-Term Growth Plans - newser.com
Humacyte releases press info on VEITH symposium presentation - Traders Union
D. Boral Capital Reiterates "Buy" Rating for Humacyte (HUMA) | H - GuruFocus
Humacyte Announces Presentations at VEITHsymposium Highlighting Positive Acellular Tissue Engineered Vessel (ATEV™) Clinical Results - The Manila Times
Humacyte (Nasdaq: HUMA) Details ATEV Recellularization and 2-Year Trauma Data - Stock Titan
What recovery options are there for Humacyte Inc. Equity WarrantWeekly Profit Summary & Long-Term Capital Growth Strategies - newser.com
Real time pattern detection on Humacyte Inc. stockPortfolio Gains Report & Step-by-Step Trade Execution Guides - newser.com
Will Humacyte Inc. Equity Warrant stock see insider buyingDividend Hike & Real-Time Stock Movement Alerts - newser.com
Will Humacyte Inc. see short term momentumJuly 2025 Sector Moves & Stepwise Trade Execution Plans - newser.com
Will Humacyte Inc. stock deliver shareholder valueJuly 2025 Summary & Risk Controlled Daily Plans - newser.com
Is Humacyte Inc. stock supported by strong cash flows2025 AllTime Highs & Low Risk Growth Stock Ideas - newser.com
How to interpret RSI for Humacyte Inc. stock2025 Valuation Update & Precise Buy Zone Identification - newser.com
Multi asset correlation models including Humacyte Inc. Equity WarrantWeekly Trade Review & Verified Short-Term Plans - newser.com
Is Humacyte Inc. Equity Warrant stock ready for a breakoutInsider Selling & Real-Time Price Movement Reports - newser.com
Is Humacyte Inc. Equity Warrant stock attractive for retirement portfolios - newser.com
Is Humacyte Inc. Equity Warrant stock attractive for growth ETFsQuarterly Trade Review & Daily Risk Controlled Trade Plans - newser.com
Will Humacyte Inc. stock benefit from infrastructure spendingEarnings Risk Summary & High Accuracy Trade Signal Alerts - newser.com
Using RSI to spot recovery in Humacyte Inc. Equity Warrant2025 Earnings Surprises & Safe Swing Trade Setup Alerts - newser.com
Humacyte Inc: Is It a Time of Strategic Shift? - StocksToTrade
Humacyte introduces Symvess at Veith Symposium - Traders Union
Technical analysis overview for Humacyte Inc. Equity Warrant stockJuly 2025 Opening Moves & Detailed Earnings Play Strategies - newser.com
Earnings visualization tools for Humacyte Inc.Market Rally & Weekly Stock Performance Updates - newser.com
Chart overlay techniques for tracking Humacyte Inc.2025 Biggest Moves & Daily Risk Controlled Trade Plans - newser.com
Can Humacyte Inc. stock reach $100 price targetJuly 2025 PostEarnings & AI Based Buy/Sell Signal Reports - newser.com
Key metrics from Humacyte Inc.’s quarterly dataQuarterly Portfolio Summary & AI Powered Market Entry Ideas - newser.com
Should I hold or sell Humacyte Inc. Equity Warrant stock in 2025Chart Signals & Verified Short-Term Plans - newser.com
Will Humacyte Inc. stock attract more institutional investorsLong Setup & Weekly Return Optimization Plans - newser.com
Is Humacyte Inc. stock trading near support levels2025 Price Targets & Reliable Breakout Stock Forecasts - newser.com
What analysts say about Humacyte Inc Equity Warrant stockMarket Breadth Indicators & Outstanding Capital Returns - earlytimes.in
Is Humacyte Inc. stock cheap compared to fundamentalsJuly 2025 Pullbacks & Expert Verified Movement Alerts - newser.com
Should You Invest in Humacyte, Inc. (HUMA) Based on Bullish Wall Street Views? - Yahoo Finance
Humacyte Inc (HUMA) 財務データ
収益
当期純利益
現金流量
EPS
Humacyte Inc (HUMA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Dougan Brady W | Director |
Aug 18 '25 |
Sale |
1.83 |
549,360 |
1,005,329 |
1,691,685 |
| Dougan Brady W | Director |
Aug 20 '25 |
Sale |
1.58 |
591,685 |
934,862 |
0 |
| Niklason Laura E | President, CEO and Director |
Aug 19 '25 |
Sale |
1.63 |
1,100,000 |
1,793,000 |
591,685 |
| Niklason Laura E | President, CEO and Director |
Aug 18 '25 |
Sale |
1.83 |
549,360 |
1,005,329 |
1,691,685 |
| Niklason Laura E | President, CEO and Director |
Aug 20 '25 |
Sale |
1.58 |
591,685 |
934,862 |
0 |
1.64%
0.70%
大文字化:
|
ボリューム (24 時間):